Financials in USD. Standardized financial statements.
A compact view of how Abingdon Health Plc turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | $8.43M | $6.13M | $4.04M | $2.83M | $11.62M | $5.24M | $2.28M | $2.27M |
| Revenue Growth? | +37.4% | +51.7% | +42.7% | -75.6% | +121.9% | +129.9% | +0.4% | 0.0% |
| Cost of Revenue? | $4.69M | $2.46M | $1.97M | $8.06M | $8.22M | $1.18M | $844,527 | $924,614 |
| Gross Profit? | $3.74M | $3.68M | $2.08M | -$5.23M | $3.39M | $4.06M | $1.43M | $1.34M |
| Gross Margin? | +44.3% | +60.0% | +51.3% | -184.4% | +29.2% | +77.5% | +62.9% | +59.2% |
| Operating Expenses? | $7.25M | $5.05M | $5.25M | $6.88M | $8.91M | $3.97M | $2.88M | $6.05M |
| Operating Income? | -$3.51M | -$1.37M | -$3.59M | -$12.11M | -$5.52M | $91,730 | -$1.45M | -$4.70M |
| EBITDA? | -$2.80M | -$916,000 | -$3.17M | -$19.89M | -$4.77M | $810,000 | -$1.10M | -$4.02M |
| Income Before Tax | -$3.50M | -$1.40M | -$3.57M | -$21.68M | -$7.05M | -$3.50M | -$1.47M | $2.93M |
| Income Tax Expense | -$81,000 | -$128,000 | -$105,000 | -$423,000 | -$81,000 | -$125,998 | -$209,660 | -$535,525 |
| Net Income? | -$3.42M | -$1.27M | -$3.47M | -$21.26M | -$6.97M | -$3.37M | -$1.26M | $3.47M |
| EPS? | $-0.01 | $-0.00 | $-0.01 | $-0.07 | $-0.07 | $-0.04 | $-0.01 | $0.04 |
| Diluted EPS? | $-0.01 | $-0.00 | $-0.01 | $-0.07 | $-0.07 | $-0.04 | $-0.01 | $0.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality